2002
DOI: 10.1590/s0074-02762002000500029
|View full text |Cite
|
Sign up to set email alerts
|

Concurrent cutaneous, visceral and ocular leishmaniasis caused by Leishmania (Viannia) braziliensis in a kidney transplant patient

Abstract: Although cases of leishmaniasis co-infection have been described in acquired immunodeficiency

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
71
0
2

Year Published

2006
2006
2021
2021

Publication Types

Select...
5
3
1

Relationship

0
9

Authors

Journals

citations
Cited by 63 publications
(73 citation statements)
references
References 16 publications
(14 reference statements)
0
71
0
2
Order By: Relevance
“…When this patient was treated with an antileishmaniacidal regimen of Amphotericin B, his meningitis resolved [43]. Finally, there are reports of patients who have cutaneous and ocular manifestations of leishmaniasis after renal transplant and immunosuppression [20].…”
Section: Recent Case Reports Of Neurologic Manifestations During Leismentioning
confidence: 90%
“…When this patient was treated with an antileishmaniacidal regimen of Amphotericin B, his meningitis resolved [43]. Finally, there are reports of patients who have cutaneous and ocular manifestations of leishmaniasis after renal transplant and immunosuppression [20].…”
Section: Recent Case Reports Of Neurologic Manifestations During Leismentioning
confidence: 90%
“…While MCL usually follows a cutaneous infection, MCL has been reported as the first clinical manifestation of AIDS even before CL or other more typical AIDS-defining illnesses (135). In a kidney transplant patient, concurrent cutaneous, visceral, and ocular leishmaniases as a result of L. braziliensis infection were also described (239). Interestingly, one report noted that 20% to 40% of HIV-infected patients with VL do not exhibit splenomegaly, which is a typical clinical feature of VL in ICT individuals (395).…”
Section: Leishmaniamentioning
confidence: 99%
“…The antimonial compounds (usually sodium stibogluconate and meglumine antimoniate), miltefosine, and amphotericin B are the mainstay of antileishmanial therapy (10,17,158,239,464,488).…”
Section: Leishmaniamentioning
confidence: 99%
“…Although DNA detection may not show the presence of viable parasites, additional results (observation of amastigotes and ELISA and IFAT positivity) confirmed the infection. Currently, L. braziliensis is considered a dermotrophic species in the human leishmaniasis disease complex, with isolation and detection of this species in the viscera only in cases of immunologically compromised patients GONTIJO et al, 2002). In wild and synantropic animals (considered potential reservoirs for L. braziliensis), such a distinction regarding tissue tropism does not exist (ROQUE et al, 2010;ROQUE & JANSEN, 2014), and the parasite may be detected in many organs.…”
Section: Discussionmentioning
confidence: 99%